Swiss and Belgian Companies Collaborate on Peptide-Based Cold Vaccines
AlgoNomics and Pevion Biotech said this week that they will collaborate to develop peptides for cold vaccines.
Over a period of a year and a half, structural bioinformatics company AlgoNomics, based in Ghent, Belgium, will use its Tripole protein modeling and peptide design technologies to develop peptides derived from Respiratory Syncytial Virus, which causes the common cold and other respiratory illnesses.
MDS Sciex Taps Unichom for Taiwanese NanoLC Distribution